Physician profile
Jory Adam
NPI 1922269521
$1,723.96
in general payments reported to CMS, 2019-2025
11 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $361 · 2022: $231 · 2023: $549 · 2024: $393 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $575.51 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Atricure, INC. | $319.71 | 2021-2023 | |
| Abiomed | $307.51 | 2023-2025 | Impella |
| Baxter Healthcare | $162.28 | 2021 | |
| Edwards Lifesciences Corporation | $91.38 | 2021-2023 | Mitris Resilia Mitral Valve |
| Smith+Nephew, INC. | $77.30 | 2023 | Renasys Go V2 Home, Pico |
| Medtronic, INC. | $70.16 | 2021 | |
| Ethicon US, LLC | $68.83 | 2021-2025 | Prolene, Evarrest |
| Lsi Solutions INC | $19.46 | 2022 | |
| Kci USA, INC. | $17.42 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $14.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jory Adam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.